Literature DB >> 22863902

Isolation of Aspergillus species from the airway of lung transplant recipients is associated with excess mortality.

T W Felton1, S A Roberts, B Isalska, S Brennan, A Philips, S Whiteside, H M Doran, C Leonard, M Al-Aloul, N Yonan, W W Hope.   

Abstract

BACKGROUND: Aspergillus spp. are the leading cause of invasive fungal infection in lung transplant recipients. We investigated the relationship between the isolation of Aspergillus spp. from the respiratory tract of lung transplant recipients and their risk of mortality.
METHODS: A retrospective, observational cohort study of all patients who received lung allografts between January 1999 and May 2011 at a single UK centre was performed. The time from transplantation to death was analysed using Cox regression models. Isolation of Aspergillus spp. from the respiratory tract was included as a covariate in the Cox regression model.
RESULTS: Two hundred-thirteen patients were included. The median follow-up time was 5 years during which 102 patients (47.9%) died. Aspergillus was isolated from 74 (34.7%) patients. Twenty patients (27%) had Aspergillus isolated in the first 60 days post-transplant. Forty-one patients (55.4%) in the Aspergillus group and 61 patients (43.9%) in the non-Aspergillus group died during follow-up. A hazard ratio of 2.2 (95% CI 1.5-3.3; P < 0.001) for death following a positive Aspergillus sample was observed.
CONCLUSION: Isolation of Aspergillus spp. from patients following lung transplantation is associated with a significant increase in mortality. Novel preventative strategies are required to minimise the impact of Aspergillus in lung transplant recipients.
Copyright © 2012 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22863902     DOI: 10.1016/j.jinf.2012.07.008

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  3 in total

1.  Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.

Authors:  M Mansh; M Binstock; K Williams; F Hafeez; J Kim; D Glidden; R Boettger; S Hays; J Kukreja; J Golden; M M Asgari; P Chin-Hong; J P Singer; S T Arron
Journal:  Am J Transplant       Date:  2015-09-03       Impact factor: 8.086

2.  Multivariate Analysis As a Support for Diagnostic Flowcharts in Allergic Bronchopulmonary Aspergillosis: A Proof-of-Concept Study.

Authors:  Joana Vitte; Stéphane Ranque; Ania Carsin; Carine Gomez; Thomas Romain; Carole Cassagne; Marion Gouitaa; Mélisande Baravalle-Einaudi; Nathalie Stremler-Le Bel; Martine Reynaud-Gaubert; Jean-Christophe Dubus; Jean-Louis Mège; Jean Gaudart
Journal:  Front Immunol       Date:  2017-08-22       Impact factor: 7.561

3.  Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United Kingdom.

Authors:  Stephanie R Earnshaw; Cheryl McDade; Andrew Bryan; Monica Ines; Christianne Micallef; Anita Sung; David A Enoch
Journal:  Microbiol Spectr       Date:  2022-05-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.